Clinical trials · Seattle, WA
Secondary Myelofibrosis clinical trials in Seattle
We’re tracking 3 recruiting secondary myelofibrosis studies with a site in or near Seattle — including Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Seattle
- NCT04370301RecruitingPhase 2
Reduced-intensity stem cell transplant with JAK inhibitor for myelofibrosis
This study tests giving a JAK inhibitor before and after a reduced-intensity stem cell transplant to treat primary or secondary myelofibrosis. The goal is to improve disease control while using a less harsh transplant approach.
Seattle, WashingtonAges 18–70 - NCT04282187RecruitingPhase 2
Decitabine plus targeted drugs for advanced blood cancer blast phase
This Phase 2 trial tests whether adding decitabine to one of three targeted medicines (ruxolitinib, fedratinib, or pacritinib) can improve outcomes in people with advanced myeloproliferative neoplasms that are progressing to a blast phase. It may help control the disease by combining blood-cancer chemotherapy with drugs that block disease-driving signaling.
Seattle, WashingtonAges 18 years+ - NCT07228624RecruitingPhase 2
Ruxolitinib before, during, and after transplant for myelofibrosis
This trial tests whether taking the drug ruxolitinib before, during, and after a stem cell transplant helps older patients with myelofibrosis or certain related blood disorders. The goal is to see if this approach can improve transplant success and reduce side effects.
Seattle, WashingtonAges 18–75
Hear when a new Secondary Myelofibrosis trial opens near Seattle, WA
We’ll email you when one opens near Seattle, WA — at most once a week, no account needed, unsubscribe anytime.
Where these studies are running near Seattle
Institutions with a site for the recruiting secondary myelofibrosis studies listed above.
- Fred Hutchinson Cancer Center · 3 studies
What taking part in a secondary myelofibrosis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting secondary myelofibrosis studies in Washington.
Common questions
- Are there secondary myelofibrosis clinical trials near Seattle?
- Yes. We're currently tracking 3 recruiting secondary myelofibrosis studies with a site near Seattle, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a secondary myelofibrosis study near Seattle?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Seattle to take part?
- Not necessarily. These studies have a site near Seattle, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a secondary myelofibrosis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New secondary myelofibrosis studies open near Seattle regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.